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The indolocarbazole biosynthetic enzymes StaC,
InkE, RebC, and AtmC mediate the degree of oxida-
tion of chromopyrrolic acid on route to the natural
products staurosporine, K252a, rebeccamycin, and
AT2433-A1, respectively. Here, we show that StaC
and InkE, which mediate a net 4-electron oxidation,
bind FAD with a micromolar Kd, whereas RebC and
AtmC, which mediate a net 8-electron oxidation,
bind FAD with a nanomolar Kd while displaying the
same FAD redox properties. We further create
RebC-10x, a RebC protein with ten StaC-like amino
acid substitutions outside of previously character-
ized FAD-binding motifs and the complementary
StaC-10x. We find that these mutations mediate
both FAD affinity and product specificity, with
RebC-10x displaying higher StaC activity than StaC
itself. X-ray structures of this StaC catalyst identify
the substrate of StaC as 7-carboxy-K252c and
suggest a unique mechanism for this FAD-depen-
dent enzyme.
INTRODUCTION
Indolocarbazoles, a subset of the L-tryptophan-derived bisindole
class of alkaloid natural products, include a variety of molecules
of pharmaceutical interest (Ryan and Drennan, 2009). Isolated
from Streptomyces species and other soil- and marine-dwelling
actinomycete bacteria (Jensen et al., 2007; Sa´nchez et al., 2006),
staurosporine (Figure 1A) has no assigned native function
but has proven to be a potent protein kinase inhibitor (Ru¨egg
and Burgess, 1989) with an analog (7-hydroxy-staurosporine,
also known as UCN-01) previously in clinical trials as an
anticancer agent (Edelman et al., 2007; Jimeno et al., 2008;
Welch et al., 2007). Rebeccamycin (Figure 1A), isolated from
Lechevalieria aerocolonigenes, shares a very similar aglycone
scaffold with staurosporine, and an analog of this compound,Chemistry & Biology 19,becatecarin, has also been in clinical trials afforded by its anti-
tumor activity (Dowlati et al., 2009; Nock et al., 2011). However,
unlike staurosporine, rebeccamycin analogs inhibit DNA replica-
tion by stabilizing DNA-topoisomerase I complexes (Bailly et al.,
1997), showing the therapeutic diversity of indolocarbazole
compounds. To exploit the full medicinal potential of indolocar-
bazoles and to generate a more diverse array of pharmaceuti-
cally active compounds, a better understanding of their biosyn-
thetic pathways and the key branch points is desirable.
The biosynthetic pathways of staurosporine, rebeccamycin,
and other indolocarbazoles involve the oxidation and subse-
quent coupling of two tryptophan molecules to generate chro-
mopyrrolic acid (CPA) (Figure 1B). At this step, the pathways
diverge to generate the diverse aglycone scaffolds characteristic
of indolocarbazoles. In the staurosporine pathway, CPA is
converted to K252c in a net 4-electron oxidation and then is
further tailored, whereas CPA is converted to arcyriaflavin A via
a net 8-electron oxidation in the rebeccamycin biosynthetic
pathway (Figure 1B). Both oxidations involve two enzymes, the
first of which, StaP or RebP, are cytochrome P450 enzymes
that catalyze aryl-aryl coupling reactions to generate a reactive
intermediate and can be used interchangeably between the
two pathways (Sa´nchez et al., 2005). The second enzyme of
each pathway, StaC or RebC, is thought to intercept this inter-
mediate and enable its conversion to the corresponding agly-
cone (Howard-Jones and Walsh, 2006). For StaC, the reaction
yields an asymmetric molecule with a carbonyl group at the
C-5 position and a fully reduced C-7 carbon (numbering in Fig-
ure 1A), whereas the product of RebC is a symmetric molecule,
with carbonyl groups at both the C-5 and C-7 positions. Without
either StaC or RebC in the reaction mix, a variety of products are
generated with varying oxidation states at the C-7 position;
however, if either enzyme is included, a single product is
observed (Howard-Jones and Walsh, 2006).
StaC and RebC share 65% sequence identity and both
enzymes contain three motifs typical of flavin hydroxylase
proteins (see Figure S1 available online) (Eppink et al., 1997;
Howard-Jones and Walsh, 2006; Ryan et al., 2007). Surprisingly
though, only RebC copurifies with FAD in Escherichia coli
recombinant expression systems. Nonetheless, StaC is capable
of converting FAD to FADH2 using NAD(P)H (Howard-Jones and855–865, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 855
Figure 1. Indolocarbazole Natural Products and
Reaction Schemes
(A) Chemical structures of rebeccamycin, AT2433-A1,
staurosporine, and K252a with standard numbering.
(B) Reaction scheme for StaP/StaC-mediated production
of K252c from CPA, and reaction scheme for StaP/RebC
mediated production of arcyriaflavin A from CPA.
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Table 1. Residues Interchanged to Generate the RebC-10x and
StaC-10x Constructs
RebC StaC Function
Glu36 Asp37 FAD binding (adenine)
Gln37 Ala38 FAD binding (adenine)
Thr38 Gly39 FAD binding (adenine)
Gln117 Ala118 FAD binding (phosphate)
Arg46 Lys47 FAD binding (isoalloxazine)
Gly48 Ser49 FAD binding (isoalloxazine)
Phe216 Val221 Substrate-binding pocket
Ala231 Ser236 Substrate-binding pocket
Arg239 Asn244 FAD (isoalloxazine) and
substrate binding
Thr241 Val246 Substrate-binding pocket
See Figure S1 for a complete sequence alignment.
Table 2. Dissociation Constants for FAD of StaC- and RebC-like
Proteins, as Determined by Isothermal Titration Calorimetry
Protein
No. of ITC
Experiments
Dissociation
Constant for FAD
StaC 3 15,000 ± 2,000 nM
InkE 4 59,000 ± 48,000 nM
RebC 5 20 ± 12 nM
AtmC 5 73 ± 28 nM
RebC-10x 3 600 ± 55 nM
StaC-10x-FADa 2 560 ± 120 nM
Curves are shown in Figure S2.
aThe FAD bound to StaC-10x could not be removed from the protein (see
text).
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and AtmC (Figure S1), are involved in separate indolocarbazole
biosynthetic pathways. Both contain the same three motifs and
the enzymes share 56% sequence identity with one another.
InkE is involved in the biosynthesis of K252a (Figure 1A) (Kim
et al., 2007), a molecule that has a carbonyl group at the C-5
position but a fully reduced C-7 carbon. The aglycone of
K252a is likely generated through a largely similar pathway as
the staurosporine aglycone, with InkE (like StaC) finalizing a net
4-electron oxidation of CPA (Figure 1B). By contrast, AtmC is
involved in the biosynthesis of AT2433-A1 (Figure 1A) (Gao
et al., 2006), a molecule that has carbonyl groups at the both
the C-5 and C-7 positions. The aglycone of AT2433-A1 is likely
generated through a highly similar pathway as the rebeccamycin
aglycone, with AtmC (like RebC) mediating a net 8-electron
oxidation of CPA (Figure 1B).
Here, we investigate the role of FAD and the enzyme mecha-
nism of RebC- and StaC-like biosynthetic enzymes. Using
isothermal titration calorimetry (ITC) to determine FAD dissocia-
tion constants for StaC, RebC, InkE, and AtmC, we find a
correlation between FAD affinity and the reaction catalyzed,
with tighter FAD affinity linked with RebC/AtmC-like activity
and weaker with StaC/InkE-like activity. To investigate whether
mutations that alter FAD affinity also alter the type of reaction
catalyzed, we use the structure of RebC (Ryan et al., 2007) in
combination with comparative sequence analysis of the enzyme
family (RebC, StaC, AtmC, and InkE) to generate a RebC protein
with ten amino acid substitutions, called RebC-10x, and the
complementary StaC-10x protein (Table 1). Excitingly, we find
that RebC-10x shows a decrease in FAD affinity (although not
to StaC levels) and exhibits strong StaC-like activity, whereas
StaC-10x shows an increase in FAD affinity (although not up to
RebC levels) and is a weak RebC-like catalyst. To probe the
molecular basis for these enzyme activity conversions, FAD
redox potentials are measured and the structure of RebC-10x
is determined in native, substrate-bound, and product-bound
states. These data, along with recent site-directed mutagenesis
studies of singly and doubly mutated RebC and StaC proteins
(Asamizu et al., 2011; Groom et al., 2011), suggest the structural
basis for the differential catalytic activities of these proteins.Chemistry & Biology 19,RESULTS
The FAD Binding Affinity Correlates with the Reaction
Catalyzed for Wild-type Enzymes
StaC, RebC, AtmC, and InkE were purified recombinantly
without the addition of exogenous riboflavin to the media. As
reported earlier, StaC purifies without bound FAD, whereas
RebC purifies with bound FAD (Howard-Jones and Walsh,
2006). Using a new cell line for protein expression (Rosetta 2
[DE3] pLysS cells from Novagen), we were able to increase
the amount of FAD copurified with RebC to 68%, from 33%
reported previously, when RebC was purified from BL21(DE3)
cells (Howard-Jones and Walsh, 2006). Furthermore, we find
that AtmC, which catalyzes a RebC-like reaction, purifies with
bound FAD, whereas InkE, which catalyzes a reaction similar
to StaC, purifies without bound FAD.
To determine the FAD dissociation constants for these four
proteins, we generated the deflavinated (apo) forms and per-
formed ITC experiments. The removal of the FAD cofactor was
unnecessary in the case of StaC and InkE, because each of
these proteins purifies without bound FAD. For RebC and
AtmC, deflavination was accomplished by washing the protein
bound to the metal affinity column with a buffer containing 2 M
KBr and 2M urea (Hefti et al., 2003). We find that the dissociation
constants (Kd) of StaC, RebC, InkE, and AtmC for FAD are 15 ±
2 mM, 20 ± 12 nM, 59 ± 48 mM, and 73 ± 28 nM, respectively
(Table 2 and Figures S2A–S2F). Although RebC and AtmC,
both of which facilitate a net 8-electron oxidation of CPA (Gao
et al., 2006; Howard-Jones and Walsh, 2006), have FAD Kd
values in the low nanomolar range, StaC and InkE, both of which
facilitate a net 4-electron oxidation of CPA (Howard-Jones and
Walsh, 2006; Kim et al., 2007), have FAD Kd values in the micro-
molar range (Table 2). These data suggest that, among this
group of enzymes, there is a correlation between, on one
hand, tight (nanomolar) binding of FAD and mediation of a net
8-electron oxidation of CPA and, on the other hand, substantially
weaker (micromolar) binding of FAD and mediation of a net 4-
electron oxidation of CPA.
StaC-10x and RebC-10x Have Similar, Intermediate
Affinities for FAD
Because of the close sequence similarity of RebC, StaC, AtmC,
and InkE, and because the structure of RebC is available (Ryan855–865, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 857
Table 3. Relative Rates of Arcyriaflavin A and K252c Production
Proteins Assayed
Rate of Arcyriaflavin
A Production (Relative
to StaP Alone)
Rate of K252c
Production (Relative
to StaP Alone)
StaP / StaC 1.1 ± 0.3 7 ± 1
StaP / RebC 14 1.0
StaP / RebC-10x 0.79 ± 0.07 20 ± 2
StaP / StaC-10x 1.7 ± 0.4 1.3 ± 0.2
Traces are shown in Figure S4.
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ences in enzymatic activity and FAD affinity between the two
groups of enzymes could be readily predicted (Figure S1). With
few exceptions, sequence alignment reveals key residues that
have one identity in both RebC and AtmC and another identity
in both StaC and InkE (Figure S1). Using the RebC crystal struc-
ture to filter out residues distant from the expected FAD-binding
and active sites, ten RebC residues and ten StaC residues were
chosen for complementary mutation to the amino acid found
in the homologous enzyme, resulting in our RebC-10x and
StaC-10x constructs (Table 1).
To assess their FAD binding affinity, these new constructs
were expressed and purified for ITC experiments. Like RebC
and AtmC, both RebC-10x and StaC-10x copurify with FAD.
RebC-10x was deflavinated in the same manner as RebC and
AtmC, and its Kd for FAD was determined to be 600 ± 55 nM
(Figure S2E and Table 2). Unlike RebC-10x, however, it was
not possible to produce apo-StaC-10x (see Experimental Proce-
dures). Therefore, as-isolated StaC-10x, which copurifies with
33% FAD occupancy, was used in ITC experiments to yield
an approximate Kd of FAD for StaC-10x of 560 ± 120 nM
(Figure S2F and Table 2). To understand the relationship of this
value to the true Kd, we determined the Kd of FAD for as-purified
RebC without removal of FAD (RebC copurifies with 68% FAD
in our expression system). The Kd of RebC for FAD determined
in this manner is 31 nM, a value within the range of values deter-
mined using fully deflavinated protein (20 ± 12 nM). Therefore,
although the Kd calculated for StaC-10x for FAD is imprecise,
we assume that the value is on the order of magnitude of the
true Kd value. Thus, by targeting ten amino acids that may be
involved in binding FAD, we have altered both StaC’s and
RebC’s affinity for FAD, suggesting successful identification of
residues important for modulating FAD affinity.
RebC-10x and StaC-10x Have Almost Identical Redox
Potentials to RebC
To determine whether the amino acid replacements had an
effect on the FAD midpoint potential, reduction potentials of
RebC-10x and StaC-10x were determined and compared to
the previously reported reduction potential of RebC, 179 mV
(Ryan et al., 2007). Using the xanthine/xanthine oxidase reduc-
tion assay (Massey, 1991; Palfey et al., 1994), the reduction
potential of FAD-bound RebC-10x was found to be 178 ±
5 mV (Figure S3A), identical within experimental error to that
of FAD-bound RebC. Interestingly, the reduction potential of
the StaC-10x FAD is also the same 178 ± 2 mV (Figure S3B).
These results show that the mutant proteins have adopted or858 Chemistry & Biology 19, 855–865, July 27, 2012 ª2012 Elsevier Lretained a flavin cofactor redox environment similar to that
found in RebC.
The 10x Mutant Proteins Have Altered Activities
Activity assays using a previously described method (Howard-
Jones and Walsh, 2006) were performed to investigate the
chemical reactivities of both 10x variants. Because the
substrate(s) of StaC and RebC have never been isolated, this
assay uses the upstream enzyme StaP and its known substrate
CPA together with an electron source provided by spinach
ferredoxin, flavodoxin NADP+ reductase, and NADPH to
generate the reactive intermediate that is the putative sub-
strate(s) for RebC and StaC. The reaction products are then
separated and analyzed via HPLC. In the presence of StaP alone,
the reaction yields multiple products, oxidized to different
degrees, including K252c (a 4-electron oxidation product), 7-
hydroxy-K252c (a 6-electron oxidation and the major product),
and arcyriaflavin A (an 8-electron oxidation product). The addi-
tion of either RebC or StaC to the assay directs the reaction to
a single major product, arcyriaflavin A for RebC and K252c for
StaC (Howard-Jones and Walsh, 2006).
Interestingly, when RebC-10x is added to the assay, no
production of the RebC product arcyriaflavin A is observed.
Instead, RebC-10x addition results in production of the StaC
product K252c, with a rate that is 3-fold faster than the rate
of the StaC-catalyzed reaction (based on authentic samples
and standard curves) (Table 3 and Figure S4). StaC-10x behaves
like RebC to the extent that it produces arcyriaflavin A as its
major product and has lost nearly all of its activity for the normal
StaC product K252c. However, it is not a strong RebC catalyst,
generating arcyriaflavin A at rates that are 8-fold lower than
that of wild-type RebC (Table 3 and Figure S4).
Structures of RebC-10x Display the Key Characteristics
of a Flavin Hydroxylase and Explain the Molecular Basis
for Decreased FAD Affinity
Crystal structures spanning three different states of the RebC-
10x reaction (native, substrate bound, and product bound)
have been determined in an effort to provide a molecular expla-
nation for the decrease in FAD affinity and gain in StaC-like
function. A single crystal structure of K252c-soaked RebC-10x
with two molecules in the asymmetric unit has afforded a view
of both native and product-bound RebC-10x states at 2.33 A˚
resolution, whereas soaking a RebC-10x crystal with StaP
substrate CPA (see below) has provided a substrate-bound
structure at 2.76 A˚ resolution (see Table 4 for data collection
and refinement statistics). Structures were solved by rigid body
refinement against the wild-type RebC structure, with mutations
confirmed by Fo Fc difference density. As expected, RebC-10x
adopts the general fold of flavin-dependent hydroxylases
(Montersino et al., 2011) with FAD-, substrate-binding, and
thioredoxin-like domains (Figure 2A). The root mean squared
deviation (RMSD) of main-chain atoms between RebC-10x and
RebC structures are less than 1 A˚, indicating that no major
conformational changes occur as a result of the ten mutations
(Figure 2A). In addition, the mutations do not appear to cause
local instability, because B-factors of the mutated sites and their
surroundings are very similar when compared to the structure of
wild-type RebC (Figure S5). Other RebC features retained intd All rights reserved
Table 4. Data Collection and Refinement Statistics
RebC-10x K252c
Soak (K252c and
Native Structures)
RebC-10X CPA Soak
(7-Carboxy-K252c
Structure)
Data Collection
Wavelength (A˚) 0.97910 0.97918
Space Group P21 P21
Cell Dimensions
A, b, c (A˚); b () 64.3, 78.6, 125.7;
99.9
63.2, 77.7, 123.1;
98.8
Resolution (A˚)a 50–2.33 (2.42–2.33) 50–2.76 (2.86–2.76)
Rsym (%)
a 8.2 (52.0) 5.4 (48.9)
<I > / s(<I > )a 19.7 (3.6) 19.6 (2.2)
Completeness (%)a 99.4 (98.5) 94.9 (97.4)
Redundancya 5.2 (4.9) 3.5 (3.5)
Total reflections 256,655 101,523
Refinement
Resolution (A˚) 41.4–2.33 50–2.76
Reflections 51,610 28,820
Rwork / Rfree
b 0.214 / 0.261 0.206 / 0.255
No. of nonhydrogen atoms
Protein 7,872 7,812
FAD /
Indolocarbazole
106 / 24 — / 54
Water 304 62
Average B-factors (A˚2)
Protein 38.1 61.7
FAD /
Indolocarbazole
40.2 / 31.1 — / 69.8
Water 35.3 52.3
Rms deviations
Bond lengths (A˚) 0.006 0.009
Bond angles () 1.0 1.6
Ramachandran statistics
Most favored
region (%)
88.5 85.7
Additionally
allowed (%)
10.9 14.0
Generously
allowed (%)
0.5 0
Disallowed
(no. of residues)
1 2
aHighest resolution shell is shown in parentheses.
bR-factor = S(jFobsj-kjFcalcj)/S jFobsj and Rfree is the R value for a test set
of reflections consisting of 5% of the diffraction data not used in refine-
ment. The same test set of reflections used in the refinement of the
RebC structures was used here.
Figure 2. Overall Structure of RebC-10x Aligned with Wild-type
RebC
(A) RebC (lighter colors) and RebC-10x (darker colors) are aligned, showing the
FAD-binding domain (red), substrate-binding domain (blue), thioredoxin-like
domain (green), and FAD (gray sticks). RMSD of main chain atoms is 0.46 A˚.
See Figure S5 for B-factor analysis.
(B) RebC-10x shows retention of the ‘‘mobile flavin,’’ where flavin binds in the
‘‘out’’ position of native RebC-10x (cyan) and in the ‘‘in’’ position when product
is bound (slate), and the ‘‘melting helix,’’ where residues 354–363 (black)
become disordered in absence of a bound indolocarbazole ligand (melting
helix termini are marked with black circles in (A)). Arg230 is labeled to help
relate this view of the active site with those shown in Figure 3 and Figure S6.
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are revealed by the structures generated through the soaking
of RebC-10x with StaC product, K252c. The ‘‘out’’ position of
the mobile flavin is observed in the molecule in the asymmetric
unit that contains no bound K252c. This FAD orientation is
associated with NADPH reduction due to the afforded solvent
accessibility (Figure 2B) (Enroth et al., 1998; Gatti et al., 1994;Chemistry & Biology 19,Ryan et al., 2007). The ‘‘in’’ position or ‘‘catalytic orientation’’ of
the mobile flavin is found in the molecule that has density for
K252c. Comparison of these two structures also shows that,
like RebC, residues 354–363 (termed the melting helix) are disor-
dered when the active site is empty and become ordered when
the active site is full (Figure 2). This melting helix region is
believed to be the entry point for substrate (Ryan et al., 2007).
Differences between RebC and RebC-10x are also observed.
As expected, multiple protein-FAD interactions are lost when the
RebC-10x structure is compared to RebC. These include the
loss of van der Waals interactions between Q37 and T38 and
the FAD adenosine moiety when these residues are replaced
by A37 and G38, resulting in a more solvent accessible cofactor
(Figure S6A); a hydrogen bond loss from E36 to the FAD ribose
when E36 is replacedwith shorter D36 (Figure S6A); a salt-bridge
loss from R46 to the FAD a-phosphate when R46 is replaced
with shorter K46 (Figure S6D); and another hydrogen bond loss
from R239 of RebC to FAD O4 in the ‘‘out’’ position, when
R239 is replaced with N239 in RebC-10x (Figure S6E).
CPA-Soaked RebC-10x Structure Reveals Putative
StaC Substrate
A structure of RebC-10x bound to its putative substrate was ob-
tained by incubating RebC-10x crystals with StaP substrate,
CPA, for one week. Previously, the putative substrate for RebC
was ‘‘trapped’’ by allowing CPA to spontaneously degrade in
the presence of RebC crystals. The crystallized RebC protein
selectively bound and stabilized its substrate (7-carboxy-
K252c) in its active site, allowing visualization (Ryan et al.,
2007). Using this same approach with the StaC catalyst RebC-
10x, indolocarbazole density was discovered in the active site
of RebC-10x (Figure S7). Because the identity of the StaC (and855–865, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 859
Figure 3. RebC and RebC-10x Substrate-
Binding Pocket
(A) RebC substrate-binding pocket (PDB ID 2R0G)
with protein backbone shown in orange and
cofactor, FAD, and substrate, enol 7-carboxy-
K252c, carbons in green and in stick representa-
tion. The side chains, Arg230, Trp276 (represent-
ing a hydrophobic region of the binding pocket),
and Pro45, are also shown in stick representation.
(B) The S-keto form of 7-carboxy-K252c as found
in molecule A of the RebC-10x CPA-soaked
crystal. Protein carbons are colored gray and
substrate shown in stick representation and
carbons colored magenta. The carboxyl group of
substrate is proximal to Arg230, as in RebC.
(C) The alternate orientation of substrate, as found
in molecule B of the RebC-10x CPA-soaked
crystal. The carboxyl group of substrate is prox-
imal to Trp276; coloring as in (B).
(D) A stereo representation of an overlay of the
RebC and RebC-10x (molecule A) active sites,
shown from above. Substrate and protein colors
the same as in (A–C); RebC side chains are labeled
in parentheses.
(E) A water molecule (red sphere) present in RebC-10x structure is located 2.6, 3.1, and 3.1 A˚ from two nitrogens of Arg230 and the C-7 position of 7-carboxy-
K252c, respectively. In all stick representations, oxygen is shown in red and nitrogen in blue (see Figure S8A for the water-binding site in the alternative orientation
of substrate). See also Figure S7 for electron difference density and omit maps.
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bazoles were modeled into the electron density, including aryl-
aryl coupled CPA, arcyriaflavin A, K252c, and the enol tautomer
of 7-carboxy-K252c, the molecule identified in the previous
RebC CPA soak (Figure 1B). Refinement of these molecules
results in significant positive and negative difference density
peaks (Figures S7A–S7D), indicating that they do not accurately
describe the electron density. However, when the S-keto
tautomer of 7-carboxy-K252c is modeled, little or no residual
Fo  Fc difference density appears (Figure S7E), and the refined
structure is the best fit to omit density maps (Figures S7G and
S7H). Thus, our data support the presence of the S-keto
tautomer of 7-carboxy-K252c in the RebC-10x active site and
suggest that this molecule is likely the substrate for StaC.
Interestingly, although RebC binds 7-carboxy-K252c with its
carboxyl group pointed toward R230 and its carbonyl in
a more hydrophobic pocket (Figure 3A), RebC-10x binds the
S-keto tautomer of 7-carboxy-K252c in two orientations that
differ by 180 (Figures 3B and 3C). One molecule in the asym-
metric unit, molecule A, binds substrate in the same orientation
as RebC (Figure 3B), whereas in molecule B, the substrate sits
in an alternate orientation, with the carbonyl pointing toward
R230 and the carboxyl group near the hydrophobic pocket
(Figure 3C). Notably, FAD is missing in these structures. During
the week-long CPA soak used to generate this crystal structure,
FAD, which binds more weakly to RebC-10x than RebC, disso-
ciates, and a loop containing residues 45–48 shifts to occupy
its site, repositioning P45 such that it now interacts with W276
(Figures 3A–3C). The absence of FAD yields a larger active
site, which can accommodate both orientations of the 7-car-
boxy-K252c. Modeling FAD in the ‘‘in’’ conformation into the
active site predicts a tight fit with substrate in either orientation,
suggesting that FAD may be in an ‘‘out’’ conformation prior to
decarboxylation or that FAD moving ‘‘in’’ might prompt decar-860 Chemistry & Biology 19, 855–865, July 27, 2012 ª2012 Elsevier Lboxylation. Importantly, regardless of FAD position, both 7-car-
boxy-K252c molecules are bound to RebC-10x in the S-keto
tautomer form, whereas the enol tautomer of 7-carboxy-K252c
was found in RebC. With active sites of StaC-catalyst RebC-
10x so similar in sequence to RebC, it is interesting to consider
the molecular basis for this preferential binding.
RebC and RebC-10x Active Site Comparisons
Although mutations were designed to alter the affinity of FAD for
the enzyme and most reside in the FAD-binding pocket, some
residues (such as G48S, T241V, F216V, and R239N) are also
near the substrate-binding site and are likely to influence both
substrate binding and reactivity (Figures S6C–S6F). Although
the loss of FAD causes a repositioning of the FAD-binding loop
(residues 39–46), most of the protein backbone in the
substrate-binding site of RebC-10x is identical to that of RebC,
allowing direct comparison of substrate-bound RebC10x to
substrate-bound RebC. A key difference between the two is
the removal of a salt bridge and hydrogen bonding interactions
between R239 and the C-7 carboxyl group and NH-6 position
of the RebC planar substrate (Figure 3D). In RebC-10x, N239 is
incapable of interacting with either the bound RebC-10x keto
substrate, or the overlaid enol tautomer from the RebC structure
(Figure 3D).
Another difference between the two active sites is the posi-
tioning of another arginine, R230. The residue, present in
both RebC and RebC-10x, sits lower in the RebC-10x active
site, apparently because of the combination of the G48S and
F216V mutations (Figure 3D). In particular, the substitution of
S for G48 sterically blocks the RebC R230 position and that
of V for F216 creates room for this residue to move down.
This ‘‘lower’’ position of R230 in RebC-10x disrupts the favor-
able interaction observed in RebC between the guanidinium
group of R230 and the 7-carboxyl of substrate in the enoltd All rights reserved
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geometry of the interaction should serve to stabilize this
orientation of the 7-carboxyl group and thus stabilize the enol
form of the substrate (Figure 3D). In contrast, the position of
R230 observed in RebC-10x has suboptimal geometry to main-
tain this interaction, and we observe instead, a new position of
the 7-carboxyl moiety and a keto tautomeric form of substrate.
This altered orientation of R230 in RebC-10x no longer interacts
with substrate, but rather appears to be involved in creation of
a new water-binding site not observed in RebC. When water is
modeled into observed positive Fo  Fc electron difference
density adjacent to R230, the difference electron density disap-
pears and the B-factor for this new water in molecules A and B,
65.0 and 58.6 A˚2, are consistent with the average B-factors
for protein atoms (62.7 A˚2) and 7-carboxy-K252c atoms
(66.1 A˚2), indicating that water is a good fit for this density.
Following refinement, the water is located 3.1 and 3.4 A˚ from
C-7 position of the RebC-10x substrate in chains A and B,
respectively (Figure 3E and Figure S8A), a position that
suggests a catalytic role (see Discussion). This water-binding
site is conserved in both the native and K252c bound RebC-
10x molecules. Overall, the active sites of RebC and RebC-
10x are similar; the bound products and substrates can be
superimposed. However, small changes in side chain positions
results in different tautomers of substrate and changes to
bound water positions.
DISCUSSION
Although the substrates for RebC and StaC can convert to the
respective products spontaneously, the presence of these
enzymes directs the reactivity toward a single product. In this
sense, RebC and StaC are babysitting enzymes, ensuring that
the appropriate reaction goes forward, but just as importantly,
preventing unwanted reactions. With such high sequence
similarly between RebC and StaC, understanding how these
enzymes catalyze their differential reactions has been a point
of considerable interest in the natural product field.
For RebC, biochemical and structural analysis helped eluci-
date the nature of the RebC substrate as 7-carboxy-K252c
(Ryan et al., 2007), indicating that conversion to product requires
both a decarboxylation and oxidation at C-7. With structural
analysis firmly placing RebC in the FAD monooxygenase
class of enzymes, it has been proposed that RebC catalyzes
both the decarboxylation and an oxidation of substrate using
FAD-dependent hydroxylase activity (Ballou, 2007; Ryan et al.,
2007). In contrast, StaC, which purifies in a deflavinated state,
does not require oxidation activity, raising the question of
whether StaC requires FAD for activity. In this work, we find a
clear correlation between FAD-binding affinities and the reaction
catalyzed, with tighter (nanomolar) binding associated with
enzymes that mediate a net 8-electron oxidation of CPA and
substantially weaker (micromolar) binding associated with the
mediation of a net 4-electron oxidation of CPA. This trend holds
for both the wild-type and mutant proteins. However, we find
that RebC-10x, which binds its FAD more tightly than StaC by
three orders of magnitude, is actually a better StaC catalyst
than StaC itself, indicating that truly weak binding of FAD is not
required for StaC-like chemistry. In contrast, StaC-10x, whichChemistry & Biology 19,binds FAD more weakly than RebC by 30-fold, is a poor RebC
catalyst. Collectively, these data imply that both StaC and
RebC are FAD-dependent enzymes in which the tight binding
of FAD is more important to the facilitation of RebC-like
chemistry. Further support for the identification of StaC as an
FAD-dependent enzyme comes from Onaka and coworkers,
who showed that StaC activity is substantially diminished
when regions of the GXGXXG FAD binding motif are mutated
(Asamizu et al., 2011).
With FAD independence ruled out as the source of StaC’s
disparate reactivity, we further considered whether variations
in substrate use and/or FAD-based mechanisms could be the
cause. Although it is difficult to envision a FAD monooxygenase
mechanism that could convert 7-carboxy-K252c to K252c,
Onaka and coworkers argued that such a mechanism could be
invoked for converting a substrate such as 5-deoxo-7-carboxy-
K252c to form K252c (Asamizu et al., 2011). To investigate the
nature of the StaC substrate, we employed the same crystallo-
graphic trick that was successful for RebC (Ryan et al., 2007):
screening CPA degradation products using enzyme crystals to
determine which molecule selectively binds. Interestingly, we
again find 7-carboxy-K252c in the active site, implying that
RebC and StaC do indeed share a common substrate. The
fact that 7-carboxy-K252c is found in the structures of both
RebC and the StaC-like catalyst RebC-10x is consistent with
the interchangeable use of the preceding enzymes (StaP and
RebP).
Given that the substrates for RebC and StaC appear to be the
same, the source of differential products must lie with the use
of a disparate FAD-based mechanism, achieved by the manner
in which each enzyme binds its substrate and the amino acid
environment near the active site. Because of the high homology
between these enzymes, small variations must be all that are
required for this shift in mechanism. Here, our structures of
substrate-bound forms of RebC and the StaC-like catalyst
RebC-10x are most informative. Although our data show
a common substrate, each enzyme active site is designed to
bind a different tautomer of that substrate. A nonplanar keto
tautomer of 7-carboxy-K252c is bound to the StaC-like catalyst,
whereas RebC binds the planar enol tautomer. Notably, there is
a key difference in the chemical reactivity of these two tauto-
mers: in the keto tautomer, the sp3 hybridized C-7 carbon can
accept electrons from the spontaneous decarboxylation of
7-carboxy-K252c (Figure 4A). In the enol form, however, sponta-
neous decarboxylation is not possible because of the sp2
hybridized C-7 carbon (Figure 4B). Thus, RebC binds 7-car-
boxy-K252c such that decarboxylation would require a change
in C-7 hybridization, likely achieved through hydroxylation of
C-7 in a FAD-dependent monooxygenase reaction (Ballou,
2007; Ryan et al., 2007) (Figure 4C), while the StaC-like catalyst
binds 7-carboxy-K252c primed for decarboxylation without
the need for hydroxylation (Figure 4A). Support for a FAD-
dependent monooxygenase mechanism for RebC includes the
observation that its mobile flavin adopts an ‘‘in’’ position in the
presence of substrate or when the FAD is reduced, such that
the substrate C-7 position is perfectly positioned near the C4a
of the isoalloxazine ring for attack on C4a-hydroperoxy-FAD,
a common flavin-dependent monooxygenase intermediate
(Ryan et al., 2007, 2008).855–865, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 861
Figure 4. Mechanistic Implications of
Substrate Tautomerization
(A) A mechanistic scheme for the decarboxylation
of S-keto 7-carboxy-K252c in a StaC-like enzyme,
where the reaction is initiated by decarboxylation.
(B) Hybridization of the C-7 carbon in the enol
tautomer of 7-carboxy-K252c makes decarbox-
ylation as the first step in the mechanism unlikely.
(C) A mechanistic scheme for RebC in which
oxidation precedes decarboxylation at the C-7
position.
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nistic proposal, its role in a StaC-like catalyst is less clear. As
described above, our data and that of the Onaka laboratory
support StaC as a FAD-dependent enzyme (Asamizu et al.,
2011), and although our redox measurements show that FAD
potentials are virtually unchanged among RebC and StaC-like
catalysts in the absence of substrate, our structural data do
not buttress the idea that StaC is a monooxygenase. Instead,
our data suggest that FAD could contribute to the catalysis of
decarboxylation through a steric and/or electrostatic mecha-
nism. In an overlay of the substrate-bound structures of RebC
and RebC-10x, the carboxyl group of substrate in RebC-10x
clashes with the FAD isoalloxazine moiety (Figure S8B–S8C),
indicating that FAD binding and/or movement of the cofactor
from the ‘‘out’’ to the ‘‘in’’ position could play a steric role in
driving decarboxylation. Alternatively, or in addition, reduced
FAD swinging ‘‘in’’ to the active site could serve to facilitate
decarboxylation through an electrostatic mechanism. Structural
data presented here show that, like RebC, the RebC-10x FAD
does transition from ‘‘out’’ to ‘‘in’’ positions. In particular, we
observe FAD ‘‘out’’ in the native RebC-10x structure and find
FAD ‘‘in’’ with the product K252c bound. In contrast to RebC,
where the FAD is ‘‘in,’’ positioned near substrate following the
week-long CPA soak (Ryan et al., 2007), here we find that FAD
dissociates from RebC-10x crystals during the same time
period. Although in agreement with a weaker FAD binding
affinity for RebC-10x, FAD dissociation during the soaking
experiment is also consistent with the notion of an unfavorably
crowded active site following substrate binding.
These two different mechanistic hypotheses for RebC and
StaC-like catalysts are also in alignment with the observed
FAD binding affinities. For RebC, tight binding of FAD is likely
important for the intricate control of the FAD cofactor required
for substrate hydroxylation, whereas for StaC-like catalysts,
precise control over FAD positioning would not be required in
a steric or electrostatic mechanism. Although tighter binding of
FAD from micromolar to high nanomolar appears to make for
a better StaC catalyst, in vivo, weaker binding of the cofactor
could allow for a single FAD to service multiple StaC enzymes.862 Chemistry & Biology 19, 855–865, July 27, 2012 ª2012 Elsevier Ltd All rights reservedIn its babysitter role, StaC protects the
7-carboxy-K252c from unwanted side-
reactions while waiting for FAD to bind.
Although organisms containing the re-
beccamycin pathway could also benefit
from shared use of FAD by multiple
RebC enzymes, in this case, weakerFAD affinity might impair catalysis to too great an extent. Here,
we find that weakening FAD affinity from low to high nanomolar
leads to a poor RebC catalyst.
Although the binding of different tautomers of 7-carboxy-
K252c by RebC and StaC-like catalysts can explain how two
highly homologous FAD-dependent enzymes can use different
mechanisms to yield their observed varied products, it is also
interesting to consider the number of amino acid changes that
are required for this differential binding of substrate. On the
basis of structural analysis, two arginines (R239 and R230) in
RebC are responsible for interacting with the 7-carboxyl moiety
of 7-carboxy-K252c and appear key to maintaining it in an enol
form, requiring RebC-like chemistry for product formation (see
Figure 3D and Results). In StaC-like enzymes, the equivalent of
R239 is asparagine, and R230 adopts an altered position due
to G48S and F216V substitutions. As we were preparing this
manuscript, two groups reported that conversion of RebC
activity to StaC-like activity can be achieved via two simulta-
neous mutations, F216V and R239N (Asamizu et al., 2011;
Groom et al., 2011), with individual mutations of these residues
leading to unchanged and dead enzyme, respectively (Asamizu
et al., 2011). These mutational data highlight the importance of
the residue at position 239 and show that the availability of the
‘‘lower’’ (StaC-like) conformation of R230, afforded by the
F216V mutation alone, is not enough to convert a RebC to
a StaC. The authors also tried the complementary mutations in
StaC and found that this construct, StaC-V221F-N244R, is not
an active RebC catalyst (Asamizu et al., 2011). Consistent with
this result, our structural data suggest that the StaC R230
equivalent, R235, cannot adopt its ‘‘RebC-like’’ orientation
unless S48 is converted to G (see Figure 3D).
Collectively, these data provide insight into the key amino
acid interactions in the RebC/StaC active sites that afford the
product specificity. For RebC activity, R239 and an ‘‘upper’’
position of R230 appear to help stabilize an enol form of 7-
carboxy-K252c, requiring the tightly bound FAD to perform
monooxygenase activity for product formation. In StaC, the
absence of arginine at position 239 and a ‘‘lower’’ position of
R230, appear to yield the preferential binding of the keto form
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tautomer would not require FAD monooxygenase activity for
conversion, perhaps using the mobile flavin as steric or electro-
static driving force for decarboxylation instead. Of course, after
decarboxylation, protonation of the C-7 carbon is required to
form the StaC product, K252c (Figure 4A). Here, we find that
the ‘‘lower’’ position of R230 creates an ordered water site that
is not present in RebC (Figure 3E). This water is in position to
act as a general acid to protonate C-7, yielding the StaC product.
Interestingly, this water molecule is present regardless of the
observed substrate orientation. As such, both orientations of
7-carboxy-K252c shown in Figures 3B and 3C seem to be cata-
lytically viable. In contrast, only one orientation of substrate is
found in the RebC structures and only that orientation has C-7
positioned correctly for hydroxylation.
SIGNIFICANCE
Natural product diversity arises in part from the tailoring of
commonmolecular scaffolds. Enzymatic pathways creating
these scaffolds are often duplicated in nature, with modifi-
cations added to generate product diversity. Frequently,
these pathways are challenging to study by traditional enzy-
mological approaches because of inherent reactivity of
the scaffold molecules, obscuring substrate and product
identification. Here we demonstrate that a crystallographic
approach can be highly informative in these types of situa-
tions. In particular, crystallography has allowed for the iden-
tification of substrates for both RebC (Ryan et al., 2007) and
StaC (this work). Also, crystallography combined with
biochemical analysis has provided insight into how enzymes
with homology to the ‘‘mobile flavin’’ class of FAD-depen-
dent monooxygenases have been co-opted to generate
RebC-like and StaC-like catalysts. Although both RebC
and StaC-like enzymes display the so-called ‘‘‘melting helix’’
modification, with residues of a helix providing an alternative
active site entrance for the large bisindole substrates, StaC
shows additional departures from traditional mobile flavin
monooxygenases. In particular, it appears to use a mobile
flavin, but not for monooxygenase activity. Instead, we
propose the mobile flavin drives a decarboxylation. With as
few as two amino acid substitutions in the active site (Asa-
mizu et al., 2011; Groom et al., 2011), RebC and StaC bind
distinct isomers of the same substrate to afford different
reaction mechanisms. Although small changes to the
molecular scaffold of a natural product can turn an inert
molecule into an antitumor drug, small changes to the
molecular scaffold of an enzyme can alter the mechanistic
role of a required cofactor and promote the formation of
a new product.
EXPERIMENTAL PROCEDURES
Generation of Expression Vectors
The generation of all expression vectors for proteins discussed in this manu-
script was carried out as described in the Supplemental Information.
Protein Purification
All protein expression vectors were transformed into chemically competent
Rosetta 2 (DE3) pLysS cells (Novagen). Single colonies were used to inoculateChemistry & Biology 19,LB media containing 30 mg/l kanamycin and 34 mg/l chloramphenicol.
Cultures were grown at 37C to an OD600 of 0.45, at which point the temper-
ature was lowered to 21C. At an OD600 of 0.65, cultures were induced
with 0.1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) and grown for
20 hr at 250 rpm. Cells were pelleted by centrifugation;, suspended in
300 mM NaCl, 25 mM Tris-HCl, and 5 mM imidazole (pH 8.0); sonicated;
and centrifuged at 25,000 rpm to pellet insoluble material. The supernatant
was incubated with nickel (II) loaded chelating sepharose fast flow (GE Biosci-
ences) for 40min at 4C. Unboundmaterial was removed; and then the column
was washed with 25 column volumes of 300 mM NaCl, 25 mM Tris-HCl, and
20 mM imidazole (pH 8.0); and then, for AtmC and RebC, were washed with
2 M KBr, 2 M urea, 300 mM NaCl, 25 mM Tris-HCl, and 20 mM imidazole
(pH 8.0) to remove bound flavin; and then were rewashed with 300 mM
NaCl, 25 mM Tris-HCl, and 20 mM imidazole (pH 8.0). Protein was eluted
with 300 mM NaCl, 25 mM Tris-HCl, and 200 mM imidazole (pH 8.0). Eluted
protein was loaded onto a Superdex-200 column pre-equilibrated with
150 mM NaCl, 25 mM HEPES, and 10% glycerol (pH 7.5), and 3 ml fractions
were collected. Fractions containing purified protein were pooled and used
directly in ITC experiments. Protein concentration was assayed using absor-
bance in the linear range at A280, using theoretical extinction coefficients
calculated for each protein by ProtParam (Gasteiger et al., 2005). For StaC-
10x and RebC-10x, protein concentration was calculated instead using the
BioRad Protein Assay (BioRad) calibrated using BSA (New England Biolabs)
as a standard.
Kd for FAD of StaC, RebC, InkE, AtmC, StaC-10x,
and RebC-10x Measured by ITC
All experiments were carried out using a MicroCal Isothermal Titration Calo-
rimeter in the MIT Biophysical Instrumentation Laboratory. FAD was removed
from RebC, AtmC, and RebC-10x as described above. Apo-protein from gel
filtration was diluted in gel filtration buffer to the desired concentration. FAD
could not be removed from StaC-10x in the same manner. After passing
a buffer containing 2M urea and 2M KBr over a metal affinity column with
bound StaC-103 to remove FAD, protein could not be eluted from the column
using any tested elution buffer. Presumably, the protein aggregated or cross-
linked to the column after the loss of FAD, requiring us to use StaC-10x with
partial FAD occupancy in this experiments. The use of non-apo StaC-10x
complicated the ITC analysis, because a fundamental assumption of Origin
Software is that the ligand concentration in the cell is zero prior to the first
injection of ligand. This limitation prompted a control experiment with RebC,
as described in text. The ITC experiments were repeated in at least triplicate,
except for the StaC-10x experiment, which was done twice (Figure S2). Equi-
librium constants of binding (Kb) were determined using the Origin Software
and were converted to equilibrium constants of dissociation (Kd). The single
binding site model was used in determining Kb.
Measurement of the Redox Potential of StaC-10x and RebC-10x
The midpoint potential of purified StaC-10x and RebC-10x were determined
using a xanthine oxidase reduction method developed by Massey (Massey,
1991). Experiments were carried out at 25C under anaerobic conditions in
a glove box using a S. I. Photonics 400 series spectrophotometer, housed
in an MBraun Labmaster glove box. The cell solution was buffered by
25 mM HEPES (pH 7.0) and contained 10% glycerol, 150 mM NaCl, 1 mM
benzyl viologen, 1 mM methyl viologen, 250 mM xanthine, 15 mM StaC-10x,
and 50 mM 1-hydroxyphenazine (1-OHP) as a reference dye (172 mV).
The addition of a catalytic amount of xanthine oxidase (Sigma Aldrich) initi-
ated the reaction, and full spectra were collected every 5 min until comple-
tion. The reduction of the StaC-10x flavin and 1-hydroxyphenazine were
monitored at 480 and 370 nm, respectively. For this technique, unlike ITC,
the level of flavin incorporation is thought to be irrelevant, because only
the flavin cofactor itself is observed spectroscopically. Hence, barring inter-
ference of apo protein with the dye molecule (which is extremely unlikely), the
presence of apo protein is not thought to influence the redox potential
determined.
Activity Assays of StaC, RebC, RebC-10x, and StaC-10x
All enzyme assays were carried out as described earlier (Howard-Jones
and Walsh, 2006) in the presence of 75 mM HEPES (pH 7.5), 1 mg/ml855–865, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 863
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reductase. All assays were carried out in triplicate, except RebC, which was
run once.
Crystallization and Structure Determinations
RebC-10x protein was purified as described above. After size exclusion, the
protein sample was concentrated to 25 mg/ml (as determined by using the
BioRad Protein Assay) using an Amicon Ultra 30K Centrifugal Filter Device
in protein buffer (150 mM NaCl, 25 mM HEPES, and 10% glycerol [pH
7.5]) and was flash frozen in liquid nitrogen for storage at 80C. Crystals
of RebC-10x were grown using the hanging-drop diffusion method at room
temperature, by incubating 1 ml of protein sample (diluted to 20 mg/ml with
protein buffer) with 1 ml of precipitant solution, 100 mM NH4F, and 20%
PEG 3350 over a 0.5 ml well of precipitant solution. After 3–4 days, rod clus-
ters would appear; these were used to generate microseeds using the Seed
Bead kit (Hampton). The seed solution was diluted 100-fold in a 50% protein
buffer and 50% precipitant solution and was used to serially streak seed 3
drops of 1 ml of 4–6 mg/ml RebC-10x (diluted in protein buffer) and 1 ml of
50 mM NH4F and 10% PEG 3350 which had been pre-equilibrated for
3 hr. Single crystals appear after 1–2 days. Solutions of CPA and K252c
for use in soaking experiments were synthesized as described elsewhere
(Howard-Jones and Walsh, 2006) (Tocris Bioscience) and were prepared at
50 and 10 mM in DMSO, respectively. The native/K252c structure was
generated from crystals that were soaked in a solution of 25 mM NH4F,
75 mM NaCl, 1 mM K252c, 12.5 mM HEPES (pH 7.5), 5% PEG 3350, and
5% glycerol for 3 hr at room temperature prior to cryocooling by washing
the crystals through a soaking solution with 20% glycerol before submerging
in liquid nitrogen. CPA-soaked crystals were prepared by incubating single
crystals in an identical soaking drop, but substituting K252c for 5 mM
CPA. These crystals were incubated at room temperature for one week
and then were washed in cyroprotectant and cryocooled as described
above.
Diffraction data to 2.15 and 2.37 A˚ resolution for K252c and CPA soaks,
respectively, were collected at Beamline 24-IDE at the Advanced Photon
Source (Argonne, IL) and were processed with HKL2000 (Otwinowski and
Minor, 1997) to 2.33 and 2.76 A˚ resolution, respectively, trimming the reso-
lution such that the I/s(I) is above 2.0 in the highest resolution bins (Table
4). Both structures were phased using a previously solved RebC CPA-
soaked structure (PDB ID 2R0G) stripped of water molecules and ligands
as a model for rigid body refinement. Topology and parameter files for
FAD, K252c, and S-keto-7-carboxy-K252c were adapted from those used
previously (Ryan et al., 2007). Iterative rounds of model building and refine-
ment were done using the programs COOT (Emsley et al., 2010), CNS
(Bru¨nger, 2007; Bru¨nger et al., 1998), and PHENIX (Adams et al., 2010). Non-
crystallographic symmetry restraints were not used in either structure
because of inherent differences of the molecules in the asymmetric unit.
No sigma cutoff was included in the refinement, and both structures were
verified using composite omit electron density maps. The final R factors
(work/free/all reflections) of 21.4/26.1/21.6 and 20.6/25.5/21.0 for K252c-
soaked and CPA-soaked structures, respectively, are within the typically
ranges for structures at or above 2.3 A˚ resolutions (Badger and Hendle,
2002). In both structures, the 20-residue N-terminal tags containing the
His6 affinity sites are disordered. In addition, the RebC-10x K252c-soaked
structure is missing residues 1–3 and 247–252 in molecule A (K252c-bound
structure) and residues 1–2, 353–364, and 418–422 in molecule B (native
structure) because of disorder. Water molecules were included at positions
where +3.5s Fo  Fc peaks were present. Water molecules in the RebC-
10x CPA-soaked structure were included only where positive Fo  Fc differ-
ence density was present and water binding sites were previously estab-
lished by higher resolution structures. In this structure, residues 1, 40–41,
248–251, and 418–425 in molecule A and residues 1, 38–40, 247–252, and
418–425 in molecule B are not included in the model. See Table 4 for refine-
ment statistics.
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